Raleigh Capital Management Inc.
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1911726
CARY, NC
Position in TMO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$36,599
-$6,164 QoQ
Shares Held
73
-16.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,453
of 2,606 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Raleigh Capital Management Inc. holds $764,974 across 5 Diagnostics & Research names. TMO ranks #4 (4.8% of the industry book) .
All Filings in TMO
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,599 | 73 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $42,763 | 87 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $42,879 | 74 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $37,346 | 77 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $34,058 | 84 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $44,286 | 89 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $103,005 | 198 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $126,188 | 204 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $115,577 | 209 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $103,455 | 178 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $55,202 | 104 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $41,505 | 82 | Shares | Sole | 2023-12-08 | |
| 2023-06-30 | $28,696 | 55 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $45,533 | 79 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $13,216 | 24 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $8,622 | 17 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,976 | 11 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $6,497 | 11 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||